Project Grant S10OD036269

Award Date 8/15/24
Completion Date 8/14/25
Dollars Obligated $1.7M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06519, USA
Similar Awards
The National Institutes of Health (NIH) awarded a $375,665 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to the University of California, Davis (UC Davis) to install an integrated radiosynthesis system for the production of non-commercially available PET radiotracers for preclinical imaging applications. The system will allow for the automated production of PET radiotracers labeled with fluorine-18, supporting the synthesis of both established and novel radiotracers. The...
This Project Grant award, totaling $708,790, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development and optimization of a modular time-of-flight positron emission tomography (TOF PET) prototype scanner with flexible geometry, based on pixelated LYSO scintillators and novel integrated photosensors. The goal is...
This $1,391,522 Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a Super Argus PET/CT 6R small-animal imaging system for the Sloan-Kettering Institute for Cancer Research in New York. The new scanner will replace the institute's aging Inveon PET/CT system, which is approaching end-of-life support from the manufacturer. The Super Argus PET/CT 6R will provide superior spatial resolution,...
This $2,000,000 Project Grant awarded by the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA #93.351) will enable Yale University to acquire a state-of-the-art 11.7T Bruker preclinical magnetic resonance imaging (MRI) system with cryogenic coil technology. The new ultra-high field MRI scanner will replace an obsolete 20-year old system, providing significantly enhanced sensitivity and resolution to support advanced functional,...
This federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1,899,234 to Vanderbilt University Medical Center (VUMC) to replace their aging MRI and PET scanners with a new integrated MRI-PET system. The award will fund the acquisition of a state-of-the-art 7T MRI scanner and a PET insert with an 80mm axial field of view, enabling simultaneous PET and MRI imaging. This updated scanner system will support over...
The University of Wisconsin-Madison received a $576,756 Project Grant award from the National Institutes of Health's Research Infrastructure Programs (CFDA 93.351) to purchase a state-of-the-art small animal PET/CT imaging scanner. This new instrument will serve as a shared resource to support NIH-funded cancer research projects at the university, improving the productivity and scientific quality of studies that seek to better understand cancer biology, radiation therapy effects, and the...
This $827,060 Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) will support the acquisition of a new Mediso NanoScan preclinical SPECT-CT scanner at Case Western Reserve University (CWRU). The new scanner will restore SPECT-CT imaging capabilities for the Cleveland region and enable a broad range of preclinical research programs at CWRU and its partner institutions, including the development of novel theranostic agents, animal...
This $609,250 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) will support the acquisition of a new automated multi-run Carbon-11 radiochemistry synthesis system for the Vanderbilt University Institute of Imaging Science's Radiochemistry Core Facility. The new system will augment the facility's existing capacity to manufacture Carbon-11 radiotracers, which are extensively utilized in preclinical...
The federal Project Grant award R01EB035144, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will develop a novel molecular imaging technology that combines positron emission tomography (PET) and ultrasound (US) imaging. The $1,541,316 award, with a period of performance from Sep 1, 2024 to May 31, 2028, aims to create a compact PET device with a...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $665,435 to The Leland Stanford Junior University (Stanford University) to develop the first system capable of simultaneous multi-tracer positron emission tomography (PET) imaging. The project aims to enable the simultaneous imaging of multiple biological processes, such as neuroinflammation, β-amyloid, phosphor-T, and neurodegeneration, which are characteristic of Alzheimer's disease....

The National Institutes of Health (NIH) Office of the Director awarded a $1,722,700 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to Yale University to acquire a state-of-the-art preclinical positron emission tomography/computed tomography (PET/CT) imaging system. This system will enhance preclinical imaging research capabilities at the Yale PET Center, supporting 19 NIH-funded investigators across multiple departments studying areas such as oncology, cardiology, psychiatry, and neurology. The new PET/CT system will improve spatial localization of radiopharmaceutical probes, enable image-based measurement of tracer input function, and provide whole-body imaging data with cardiac and respiratory motion correction. This instrumentation upgrade is expected to promote the development of novel radiopharmaceuticals and advance research into new diagnostic and therapeutic approaches for human diseases, with the potential to significantly benefit public health.

Generated 7/15/25, 8:00 AM